Intelligent Intervention Into Multiple Sclerosis With Next-generation Therapies

Video Jul 13, 2020 | Taken from Scripps Research, YouTube

As scientists learn more about the underlying causes of multiple sclerosis (MS), they are developing intelligent interventions that slow or halt the progression of the disease.

In this Front Row lecture, Scripps Research Professor Hugh Rosen will share how he and his collaborators at Scripps Research created ozanimod (Zeposia), the first disease-altering MS therapy, recently approved in the United States and Europe.

Luke Lairson, an associate professor at Scripps Research, will discuss how his research targeting another aspect of the disease is laying the groundwork for the next generation of MS therapies.

Recommended Videos

How Can Mindfulness Help During the COVID-19 Pandemic?

Video

In this interview, Johns Hopkins Assistant Professor Dr Neda Gould explains how mindfulness can benefit the brain, especially during the stressful period of the coronavirus pandemic.

WATCH NOW

Teach Me in 10 – The Vagus Nerve and COVID-19 With Dr Paul-Peter Tak

Video

Nicknamed "the wanderer", the vagus nerve plays a variety of interesting roles in our body. Now, researchers are exploring whether vagus nerve stimulation is a viable treatment option for COVID-19. Immunologist Dr Paul-Peter Tak teaches us more in this installment of Teach Me in 10.

WATCH NOW

How Childhood Trauma Affects Health Across a Lifetime

Video

Pediatrician Nadine Burke Harris explains that the repeated stress of abuse, neglect and parents struggling with mental health or substance abuse issues has real, tangible effects on the development of the brain.

WATCH NOW

Like what you just watched? You can find similar content on the communities below.

Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free